Sale!

ACADL Gene LCAD Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ACADL Gene LCAD Deficiency NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the ACADL gene responsible for Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency. This inherited metabolic disorder affects the body’s ability to break down long-chain fatty acids for energy production. Using Next-Generation Sequencing (NGS) technology, this comprehensive test provides accurate detection of genetic variants that can lead to life-threatening metabolic crises, especially during fasting or illness. Early identification through this $500 USD test enables proactive management strategies, dietary modifications, and preventive care measures. The test is particularly crucial for individuals with family history of metabolic disorders, unexplained hypoglycemia, or recurrent episodes of metabolic decompensation. Results are typically available within 3-4 weeks from blood sample collection.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ACADL Gene LCAD Deficiency NGS Genetic DNA Test

Comprehensive Genetic Screening for Metabolic Health

The ACADL Gene LCAD Deficiency NGS Genetic DNA Test represents a breakthrough in preventive genetic medicine, offering comprehensive screening for Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency. This inherited metabolic disorder disrupts the body’s ability to properly metabolize long-chain fatty acids, potentially leading to severe health complications when left undiagnosed. Our advanced Next-Generation Sequencing technology provides unparalleled accuracy in detecting genetic mutations that could impact your metabolic health and overall wellbeing.

What Does This Test Measure?

This sophisticated genetic analysis specifically targets the ACADL gene, which encodes the enzyme responsible for the initial step in mitochondrial fatty acid beta-oxidation. The test identifies:

  • Pathogenic variants and mutations in the ACADL gene
  • Single nucleotide polymorphisms (SNPs) affecting enzyme function
  • Deletions, insertions, and copy number variations
  • Both homozygous and heterozygous carrier states
  • Novel genetic variants with potential clinical significance

Who Should Consider This Genetic Screening?

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Unexplained episodes of hypoglycemia (low blood sugar)
  • Recurrent metabolic decompensation during fasting or illness
  • Family history of sudden infant death syndrome (SIDS)
  • Muscle weakness, fatigue, or exercise intolerance
  • Developmental delays in children
  • Liver dysfunction or hepatomegaly
  • Cardiomyopathy or heart rhythm abnormalities
  • Previous unexplained metabolic crises

Significant Benefits of Early Detection

Early identification of LCAD deficiency through genetic testing provides numerous advantages:

  • Preventive Management: Enables implementation of dietary modifications before symptoms manifest
  • Crisis Prevention: Helps avoid life-threatening metabolic emergencies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Treatment: Allows for tailored medical management strategies
  • Peace of Mind: Reduces uncertainty and anxiety about genetic risks
  • Proactive Healthcare: Facilitates early intervention and monitoring

Understanding Your Test Results

Interpretation Guidelines

Your genetic test results will be carefully analyzed and presented with comprehensive explanations:

  • Positive Result: Indicates the presence of pathogenic variants associated with LCAD deficiency. Our genetic counselors will provide detailed guidance on management strategies.
  • Negative Result: Suggests no detected mutations in the ACADL gene, significantly reducing the likelihood of LCAD deficiency.
  • Variant of Uncertain Significance (VUS): Some genetic changes may require additional family studies or research for proper interpretation.
  • Carrier Status: Identifies individuals who carry one copy of a mutated gene but typically don’t show symptoms.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic testing facilities ensures consistent quality and reliable results nationwide.

Take Control of Your Genetic Health Today

Don’t leave your metabolic health to chance. The ACADL Gene LCAD Deficiency NGS Genetic DNA Test provides the clarity and confidence you need to make informed healthcare decisions. Our team of genetic specialists and metabolic experts are ready to support you through every step of the testing process.

Ready to schedule your genetic screening? Contact our genetic counseling team at +1(267) 388-9828 or book your appointment online today. Take the first step toward understanding your genetic blueprint and protecting your metabolic health for years to come.